首页> 外文期刊>Modern Pathology >Expression of CXCL13, a chemokine highly upregulated in germinal center T-helper cells, distinguishes angioimmunoblastic T-cell lymphoma from peripheral T-cell lymphoma, unspecified
【24h】

Expression of CXCL13, a chemokine highly upregulated in germinal center T-helper cells, distinguishes angioimmunoblastic T-cell lymphoma from peripheral T-cell lymphoma, unspecified

机译:CXCL13(在生发中心T辅助细胞中高度上调的趋化因子)的表达将血管免疫母细胞性T细胞淋巴瘤与外周T细胞淋巴瘤区分开

获取原文
           

摘要

The germinal center T-helper cell has been proposed as the cell of origin for angioimmunoblastic T-cell lymphoma. Our recent report of expression of CXCL13, a chemokine critical for germinal center formation and one of the most highly upregulated genes in the germinal center T-helper cell subset, in the majority of angioimmunoblastic T-cell lymphoma cases, provided further support for this theory. To determine the specifity of this marker for angioimmunoblastic T-cell lymphoma, we evaluated CXCL13 expression in 26 nodal-based peripheral T-cell lymphomas and 14 lymph nodes showing paracortical lymphoid hyperplasia. No significant paracortical CXCL13 staining was seen in the reactive lymph nodes. By WHO classification criteria, 20 of the lymphoma cases were considered peripheral T-cell lymphoma, unspecified, and six were reclassified as angioimmunoblastic T-cell lymphoma after immunohistochemical detection of disorganized follicular dendritic cell meshworks. Combining the results of our studies, 31 of 35 angioimmunoblastic T-cell lymphoma cases (89%) showed CXCL13 expression, in contrast to two out of 20 peripheral T-cell lymphoma, unspecified cases (10%). The two peripheral T-cell lymphoma, unspecified cases that were positive for CXCL13 showed a Lennert lymphoma-like histology. While these cases did not meet all histologic criteria for angioimmunoblastic T-cell lymphoma, they did show an increase in EBV-positive B cells, suggesting they may be histologic variants of angioimmunoblastic T-cell lymphoma. In conclusion, CXCL13 expression is a distinctive feature of angioimmunoblastic T-cell lymphoma, providing further support for the germinal center T-helper cell as the cell of origin for this neoplasm. Given its specificity when compared to cases of peripheral T-cell lymphoma, unspecified as well as paracortical lymphoid hyperplasia, it may be a useful marker in the diagnosis of angioimmunoblastic T-cell lymphoma.
机译:已提出生发中心T辅助细胞是血管免疫母细胞T细胞淋巴瘤的起源细胞。我们最近发表的有关CXCL13表达的报告,CXCL13是一种对生发中心形成至关重要的趋化因子,并且在大多数血管免疫增生性T细胞淋巴瘤病例中,是生发中心T辅助细胞亚群中最上调的基因之一,为这一理论提供了进一步的支持。 。为了确定该标记物对血管免疫母细胞性T细胞淋巴瘤的特异性,我们评估了26例基于淋巴结的外周T细胞淋巴瘤和14个显示皮质下淋巴样增生的淋巴结中的CXCL13表达。在反应性淋巴结中未见明显的皮层旁CXCL13染色。根据WHO分类标准,在免疫组织化学检测到无组织的滤泡性树突状细胞网状组织后,其中20例淋巴瘤病例被认为是外周T细胞淋巴瘤,未明确,其中6例被重新分类为血管免疫母细胞性T细胞淋巴瘤。结合我们的研究结果,在35例血管免疫母细胞性T细胞淋巴瘤病例中,有31例(89%)表现出CXCL13表达,而在20例外周T细胞淋巴瘤中,有2例未发现病例(10%)。 CXCL13阳性的两个外周T细胞淋巴瘤(未指明)显示了Lennert淋巴瘤样组织学。尽管这些病例不符合血管免疫母细胞性T细胞淋巴瘤的所有组织学标准,但它们确实显示出EBV阳性B细胞增多,表明它们可能是血管免疫母细胞性T细胞淋巴瘤的组织学变异。总之,CXCL13表达是血管免疫母细胞性T细胞淋巴瘤的独特特征,为生发中心T辅助细胞作为该肿瘤的起源细胞提供了进一步的支持。与外周T细胞淋巴瘤(未明确说明)以及皮质旁淋巴样增生相比,它具有特异性,因此在诊断血管免疫母细胞性T细胞淋巴瘤时可能是有用的标记物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号